x
02/2021 Portfolio

INVESTING ON THE EDGE OF SCIENCE

As a deep tech investor, we believe in science, its innovative power and its potential to sustainably improve the quality of tomorrow’s life. That is why the majority of our portfolio consists of successful spin-offs from universities and research institutions, which provide the basis for successful companies by researching groundbreaking innovations.

We are now particularly proud that all of our new investments in 2020 have made it onto the Forbes list of the “30 Spin-offs to Watch 2021” in the DACH region. This shows once again that OCCIDENT anticipates the potential for success early on and makes the right investment decisions.

Congratulations also to the great founding teams of hemotune, Tubulis and Code Intelligence!

More about (only in German language)

02/2021 Portfolio

ADIVO CONCLUDES FURTHER GLOBAL COLLABORATION AGREEMENT

Our portfolio company adivo has succeeded in entering into another partnership with one of the leading animal health companies to develop therapeutic antibodies for companion animals. Under the terms of the collaboration agreement, the animal health company will gain access to adivo’s species-specific monoclonal antibody technology.

More about

02/2021 Portfolio

CODE INTELLIGENCE'S FUZZ TESTING IS OPEN SOURCE

After Google released an open source fuzzer for Python in December, our portfolio company Code Intelligence now enables modern fuzz testing for the Java Virtual Machine (JVM) with Jazzer.

Using automated software security testing for developers, Jazzer can increase test coverage and find edge cases to more effectively locate software bugs. No changes to code or build system are required. Jazzer supports not only the JVM, but also programming language mixing.

More about Code Intelligence

02/2021 team

WELCOME LISA

OCCIDENT is pleased to welcome another new member to the team and welcomes Lisa Maier as new Team Assistant & Office Manager at the Zug office. In addition to her studies in Media and Communication, Lisa has gained professional experience in the areas of marketing, event organization and team assistance in the medical technology industry.

01/2021 About

WE ARE ONCE AGAIN CLIMATE NEUTRAL

Even though corona is an omnipresent topic, we do not want to forget about climate change and the associated negative consequences. As a sustainable company, we wish to make our contribution to climate protection. We have calculated our corporate carbon footprint for the year 2020 and, based on this, support projects to reduce CO2 emissions in cooperation with the Swiss foundation myclimate.

More about myclimate

01/2021 team

WELCOME AAGAM

OCCIDENT welcomes Aagam Shah as new Investment Analyst for the life sciences sector at the Zug office. Aagam studied Biomedical Engineering at Johns Hopkins University and holds a PhD in Neurotechnology from ETH Zurich. His previous professional experience was in the fields of medical technology, neuroscience and cardiovascular research. At OCCIDENT, Aagam supports the comprehensive analysis and due diligence of new investment opportunities.

12/2020 Portfolio

GNA RECEIVES AUTHORIZATION

Fantastic achievement by our portfolio company GNA Biosolutions. The Munich based company receives emergency use authorization from the German Health Authority BfArM for its ultrafast molecular covid testing system. This represents a significant step in getting the pandemic under control.

Congratulations to the whole team!

More about

12/2020 About

LET'S SHOW INITIATIVE!

“If we take the future seriously, we must stop leaving it up to others and become active ourselves.” (Jane Goodall)

Especially the last year with all the new challenges has taught us how important it is to show initiative and to become active ourselves. We have all learned that you can make your own contribution and that you should not leave it to others. We were confirmed how important science and research are. We were made aware that in the future, innovation will become increasingly important, and that it will become more and more important that each individual can make a difference.

With this in mind, we would like to thank you for the enriching and inspiring cooperation this year in particular and look forward to tackling the challenges together to sustainably improve tomorrow’s life.

The OCCIDENT Team wishes you a peaceful, inspiring Christmas season and a fantastic year in 2021.

11/2020 Portfolio

SWISS TECHNOLOGY AWARD FOR HEMOTUNE

Congratulations to our portfolio company hemotune on winning the Swiss Technology Award in the startups category. Another great achievement for this innovative medical technology start-up dedicated to the fight against sepsis.

More about hemotune (video)

Show more